Kcl + Glucose, Viaflo Baxter (Potassium Chloride, Glucose)

Kcl + Glucose, Viaflo Baxter is used to manage electrolyte and carbohydrate needs in several clinical situations.

• Hypokalemia: restores serum potassium to normal levels, preventing cardiac and muscular complications.
• Potassium supplementation: provides essential potassium ions for patients with deficient intake or losses.
• Fluid and electrolyte replenishment: corrects deficits in body fluids and electrolytes during dehydration or illness.
• Prevention or treatment of hypoglycemia: supplies glucose to raise blood sugar and support metabolic demands.
• Post‑operative or peri‑operative fluid management: maintains electrolyte balance and energy supply during surgical recovery.

• The injection delivers potassium chloride, which dissociates to release potassium ions that are taken up by cells, raising extracellular potassium concentration and correcting hypokalemia. Simultaneously, glucose provides a readily metabolizable carbohydrate that enters the bloodstream, serving as an energy substrate and stimulating insulin release, which facilitates cellular uptake of potassium and supports metabolic homeostasis. The combined solution also contributes to osmotic balance, aiding fluid distribution across vascular compartments.

Kcl + Glucose, Viaflo Baxter may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects

• Injection site irritation: redness, pain, or swelling at the infusion site.
• Hyperkalemia: elevated serum potassium levels, especially with rapid infusion.
• Hyperglycemia: transient rise in blood glucose concentrations.
• Nausea or vomiting: gastrointestinal discomfort following administration.
• Headache: mild to moderate head pain.
• Dizziness: feeling of light‑headedness or imbalance.

Serious or Rare Side Effects

• Cardiac arrhythmia: potentially life‑threatening rhythm disturbances due to potassium imbalance.
• Severe hyperkalemia: risk of cardiac arrest if potassium exceeds safe limits.
• Anaphylactic reaction: rare hypersensitivity with rash, bronchospasm, or hypotension.
• Severe hyperglycemia: may precipitate diabetic ketoacidosis in susceptible patients.
• Thrombophlebitis: inflammation of vein with clot formation at infusion site.
• Metabolic acidosis: rare disturbance of acid‑base balance.

When using Kcl + Glucose, Viaflo Baxter, clinicians should observe specific safety measures to minimize risks.

• Renal impairment: monitor serum potassium and adjust infusion rate.
• Cardiac disease: obtain baseline ECG and watch for arrhythmias.
• Diabetes mellitus: check blood glucose frequently and titrate glucose infusion.
• Concomitant potassium‑sparing agents: avoid combined use to prevent hyperkalemia.
• Pregnancy: prescribe only if potential benefit outweighs risk to the fetus.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kcl + Glucose, Viaflo Baxter can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid)

• ACE inhibitors or ARBs: may potentiate hyperkalemia.
• Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation.
• Digitalis glycosides: heightened risk of cardiac toxicity with high potassium.

Moderate Interactions (Monitor Closely)

• Insulin therapy: glucose infusion may require insulin dose adjustment.
• Beta‑blockers: may mask signs of hypoglycemia during glucose administration.